967 related articles for article (PubMed ID: 31390155)
1. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
3. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
Kjær SK; Munk C; Junge J; Iftner T
Cancer Causes Control; 2014 Feb; 25(2):179-89. PubMed ID: 24242002
[TBL] [Abstract][Full Text] [Related]
5. Detection and Genotyping of HPV DNA in a Group of Unvaccinated Young Women from Colombia: Baseline Measures Prior to Future Monitoring Program.
Puerto D; Reyes V; Lozano C; Buitrago L; Garcia D; Murillo RH; Muñoz N; Hernandez GA; Sanchez L; Wiesner C; Combita AL
Cancer Prev Res (Phila); 2018 Sep; 11(9):581-592. PubMed ID: 29991579
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
7. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
8. Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
Lou H; Gharzouzi E; Guerra SP; Fokom Domgue J; Sawitzke J; Villagran G; Garland L; Boland JF; Wagner S; Rosas H; Troxler J; McMillen H; Kessing B; Alvirez E; Castillo M; Morales H; Argueta V; Rosingh A; van Aerde-van Nunen FJHB; Lopez G; Pinedo HM; Schiffman M; Dean M; Orozco R
BMC Cancer; 2018 May; 18(1):562. PubMed ID: 29764400
[TBL] [Abstract][Full Text] [Related]
9. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia.
Bondagji NS; Gazzaz FS; Sait K; Abdullah L
Ann Saudi Med; 2013; 33(1):13-7. PubMed ID: 23458934
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.
Chaopotong P; Laiwejpithya S; Areeswate C
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1241-1245. PubMed ID: 38679983
[TBL] [Abstract][Full Text] [Related]
14. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the most common types of HPV in Iranian women with and without cervical cancer.
Farahmand Z; Soleimanjahi H; Garshasbi M; Hasanzadeh M; Zafari E
Women Health; 2021 Jan; 61(1):73-82. PubMed ID: 32957835
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.
AlObaid A; Al-Badawi IA; Al-Kadri H; Gopala K; Kandeil W; Quint W; Al-Aker M; DeAntonio R
BMC Infect Dis; 2014 Dec; 14():643. PubMed ID: 25496614
[TBL] [Abstract][Full Text] [Related]
19. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
20. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
